EPISODE · Feb 16, 2026 · 37 MIN
Hansa Biopharma On Clearing The Path To Kidney Transplant
from Citeline Podcasts · host Norstella
Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribulations of completing a Phase III program.
What this episode covers
Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribulations of completing a Phase III program.
NOW PLAYING
Hansa Biopharma On Clearing The Path To Kidney Transplant
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m